Internal Medicine, Hematology & Oncology · Edmond, OK
NPI
1952508533
Since 2007
Specialty
Internal Medicine, Hematology & Oncology
Code 207RH0003X
Group practices
4
Medicare group memberships
Hospitals
5
Hospital affiliations
13301 N Meridian Ave, Suite 501
Edmond, OK, 73120
Phone (405) 752-0872
Groups this clinician bills Medicare through
Medicare paid, 2024
$7.3M
206,596 services
Medicare patients, 2024
876
Average age 75
Drug cost, 2024
$18.2M
3,787 prescriptions
Company payments, 2025
$8,885
From 41 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Sanjaykumar J Hapani was code J9271 (injection, pembrolizumab, 1 mg), 22,500 times for 14 patients. In total Sanjaykumar J Hapani billed 206,596 services in 114 codes, and Medicare paid $7.3M.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2026-07-20.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| J9271 Injection, pembrolizumab, 1 mg | Office | 22,500 | 14 | $44.26 | $996K |
| J0897 Injection, denosumab, 1 mg | Office | 15,720 | 41 | $20.36 | $320K |
| J1437 Injection, ferric derisomaltose, 10 mg | Office | 15,400 | 113 | $15.87 | $244K |
| 99214 Office E&M - Established | Office | 2,293 | 668 | $94.39 | $216K |
| J1100 Injection, dexamethasone sodium phosphate, 1 mg | Office | 2,028 | 28 | $0.09 | $181 |
| J2469 Injection, palonosetron hcl, 25 mcg | Office | 623 | 14 | $0.67 | $420 |
| 96413 Chemotherapy Administration | Office | 456 | 50 | $95.56 | $44K |
| 96372 Injection Administration | Office | 450 | 79 | $10.82 | $4,869 |
| G2211 Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's | Office | 351 | 232 | $13.02 | $4,569 |
| 96365 Intravenous Infusion, Hydration | Office | 302 | 135 | $46.04 | $14K |
| 99205 Office E&M - New | Office | 289 | 288 | $162.63 | $47K |
| 96375 Injection Administration | Office | 199 | 28 | $11.54 | $2,296 |
| 99213 Office E&M - Established | Office | 190 | 136 | $65.84 | $13K |
| 96367 Intravenous Infusion, Hydration | Office | 139 | 28 | $21.37 | $2,970 |
| J7030 Infusion, normal saline solution , 1000 cc | Office | 114 | 26 | $2.03 | $231 |
By year: 2022 $7.7M for 217,299 services; 2023 $8.2M for 269,281 services; 2024 $7.3M for 206,596 services.
Lab tests billed to Medicare, 2024
| Test code | Tests | Patients | Paid per test | Medicare paid |
|---|---|---|---|---|
| 36415 Venipuncture Blood Collection | 33 | 23 | $8.65 | $285 |
| 85025 Blood Count | 26 | 17 | $7.61 | $198 |
Medicare prescription drug claims, 2024
In 2024, the drug Sanjaykumar J Hapani prescribed most often to Medicare patients was Procrit (Epoetin Alfa), with 481 prescriptions and refills. In total Sanjaykumar J Hapani wrote 3,787 Medicare prescriptions that cost $18.2M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Procrit Epoetin Alfa | 481 | 481 | 85 | $1.7M |
| Xgeva Denosumab | 246 | 246 | 35 | $768K |
| Abiraterone Acetate Generic | 238 | 238 | 31 | $540K |
| Octagam Immun Globg(Igg)/Malt/Iga Ov50 | 190 | 190 | 23 | $2.5M |
| Xtandi Enzalutamide | 185 | 185 | 23 | $2.6M |
| Oxycodone Hcl Generic | 145 | 145 | 31 | $2,032 |
| Imbruvica Ibrutinib | 139 | 139 | 16 | $2.2M |
| Nyvepria Pegfilgrastim-Apgf | 121 | 121 | 23 | $454K |
| Acyclovir Generic | 111 | 166 | 24 | $2,769 |
| Prednisone Generic | 110 | 208 | 38 | $1,007 |
| Letrozole Generic | 87 | 173 | 18 | $6,649 |
| Hydroxyurea Generic | 75 | 145 | 21 | $1,612 |
| Potassium Chloride Generic | 69 | 85 | 32 | $798 |
| Ondansetron Odt Ondansetron | 62 | 62 | 31 | $801 |
| Eliquis Apixaban | 52 | 82 | 12 | $46K |
Brand drugs: 2,062 claims; generic drugs: - claims; opioid claims: 312.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Sanjaykumar J Hapani $8,885 ($8,885 in general payments such as food, travel and fees) from 41 companies. The largest payer was OnMark, Inc. with $2,720.
| Company | Payments | Amount |
|---|---|---|
| OnMark, Inc. | 10 | $2,720 |
| Novartis Pharmaceuticals Corporation NVS | 20 | $1,381 |
| Incyte Corporation INCY | 4 | $940 |
| Daiichi Sankyo Inc. 4568.T | 3 | $704 |
| Pfizer Inc. PFE | 29 | $433 |
| Celltrion USA Inc. 068270.KS | 2 | $334 |
| Cardinal Health 110 LLC | 1 | $275 |
| Abbvie Inc. ABBV | 11 | $211 |
| Alexion Pharmaceuticals, Inc. AZN | 2 | $202 |
| Merck Sharp & Dohme LLC MRK | 7 | $160 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.